CeloNova BioSciences, Inc. is an innovative global medical device leader transforming the treatment of cardiovascular disease and promoting positive outcomes in patients around the world. CeloNova BioSciences develops, manufactures and markets a family of products based upon its novel Polyzene™-F nanocoating technology. This next-generation nanocoating is the result of years of rigorous scientific research and German-engineering, and has been widely published in numerous academic articles to date.